Tinkeso Therapeutics

Cell therapy for oncology and autoimmune diseases.

Tinkeso Therapeutics operates in therapeutics based in United States, founded in 2016.

Profile

Novel allogeneic Natural Killer T (NKT) cell therapies for oncology and autoimmune diseases.

As a business in therapeutics, Tinkeso Therapeutics is listed here with the public details available about it.

Its base of operations is United States.

Directory data places it at the SOSV portfolio company stage.

The company reports a headcount in the 2-10 range.

Website: tinkeso.com